CDx success insights from Xalkori and Zelboraf

JoshLowth · 04-24-2012, 12:15 AM

4th Molecular Diagnostics for Cancer Drug Development
Meet the oncology and diagnostics experts you need to deliver better, safer drugs to market quicker
25 - 28 June 2012, Boston
www.moleculardiagnostics-cancer.com

Featuring 31 expert speakers, including:

Dr Richard Buller, Vice President, Translational Oncology, Pfizer
Dr Miu Chau, Global Head, Companion Diagnostics Operations, Genentech
Dr Mitch Raponi, Senior Director, Molecular Diagnostics & Translational Medicine, Clovis Oncology

This meeting will profile those at the cutting edge of personalized medicine in oncology to give you a thorough review of best practice in end to end drug and diagnostic development from discovery to commercialization.

For more information please visit the website: www.moleculardiagnostics-cancer.com or get in touch on info@hansonwade.com.

Josh Lowth
Hanson Wade

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
Whole-genome sequencing data offer insights into human demography	KerryOdair	Personalized Genomics	0	03-07-2012 10:05 AM
Success of Solexa-platform	Susanne	General	8	11-21-2009 05:39 AM
PubMed: High-throughput sequencing provides insights into genome variation and evolut	Newsbot!	Literature Watch	0	07-22-2008 05:06 AM

04-24-2012, 12:15 AM	#1
JoshLowth Junior Member Location: London Join Date: Apr 2012 Posts: 4	CDx success insights from Xalkori and Zelboraf 4th Molecular Diagnostics for Cancer Drug Development Meet the oncology and diagnostics experts you need to deliver better, safer drugs to market quicker 25 - 28 June 2012, Boston www.moleculardiagnostics-cancer.com Featuring 31 expert speakers, including: Dr Richard Buller, Vice President, Translational Oncology, Pfizer Dr Miu Chau, Global Head, Companion Diagnostics Operations, Genentech Dr Mitch Raponi, Senior Director, Molecular Diagnostics & Translational Medicine, Clovis Oncology This meeting will profile those at the cutting edge of personalized medicine in oncology to give you a thorough review of best practice in end to end drug and diagnostic development from discovery to commercialization. For more information please visit the website: www.moleculardiagnostics-cancer.com or get in touch on info@hansonwade.com. Josh Lowth Hanson Wade